Looking for exceptional Pharmacokinetic, Bioequivalent, Toxicokinetic or Residual studies?

Thanks to our advanced technology, techniques, and highly sensitive ICP/MS tech, QUINTA-ANALYTICA’s bioanalytical department is capable of conducting elemental analyses of extremely minute trace elements in biological matrices such as urine, plasma, blood serum & tissues.

With very low detection limits in the order of parts per billion, we can determine the given element not only in terms of total concentration, but also the form in which the monitored element is contained in the given matrix (using speciation analysis). This is essential for assessing the efficacy of drugs or dietary supplements containing trace elements.

A perfect example: a methodology we’re currently establishing to determine serum iron after administration of a colloidal form of iron (i.e. Ferric carboxymaltose) used in the treatment of anaemia. Our analyses can be used to determine both total iron in the blood serum plus its individual forms (labile iron, iron bound to transferrin, colloidal iron).

We think that’s pretty cool!

Curious to know how we do it, or more about our services? Get in touch.

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.